Press "Enter" to skip to content

New patent for Rhythm drug IMCIVREE

0
Copyright © DrugPatentWatch. Originally published at New patent for Rhythm drug IMCIVREE

Annual Drug Patent Expirations for IMCIVREE
Annual Drug Patent Expirations for IMCIVREE

Imcivree is a drug marketed by Rhythm and is included in one NDA. There are two patents protecting this drug.

This drug has forty-three patent family members in seventeen countries.

The generic ingredient in IMCIVREE is setmelanotide acetate. Additional details are available on the setmelanotide acetate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Rhythm drug IMCIVREE
DrugPatentWatch - Make Better Decisions